IP Library Granted Patent US 8,921,278
Granted Patent B2
US 8,921,278 · App. 11/387,553 · Granted Dec 30, 2014

Method for the discovery of high-affinity, high specificity oligonucleotide and derivatized oligonucleotide sequences for target recognition

Inventors: Bruce S. Hudson (Syracuse, NY); Philip N. Borer (Chittenango, NY)
Assignee: Syracuse University
G01N33/5308C12Q1/6837G01N2333/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,921,278
App. No.
11/387,553
Granted
Dec 30, 2014
Kind
B2
Abstract

A method is disclosed to obtain oligonucleotide sequences with high affinity to target molecules. By design, the oligonucleotides have a defined primary and secondary structure. The affinity for binding to target species is classified or quantified by assay measurements using physical measurements rather than being based primarily on separations. Targets include but are not limited to proteins, polymers, biological membranes including cells and organelles and small molecules.

Claims (30)

1. A method of obtaining combimers that bind to a target at a desired binding affinity, comprising the steps (a) through (d) in the following order:

(a) designing an oligonucleotide library comprising oligonucleotides or analogs thereof having known primary and secondary structure, each of which comprises a constant region and a variable region comprising N enumerated base positions in a combimer loop region of the oligonucleotide or analog thereof, wherein each enumerated base position comprises one of X selected nucleotide bases, such that the oligonucleotide library comprises up to X N different oligonucleotides or analogs thereof, and wherein the nucleotide sequence is systematically modified to create a family of sequence variants, and wherein the region of the nucleotide sequence which is varied is said to be enumerated;

(b) synthesizing at least some of the oligonucleotides or analogs thereof of the oligonucleotide library;

(c) classifying or quantifying the binding affinity of the combimer loop region of each oligonucleotide or analog thereof for the target; and

(d) identifying combimers with the desired binding affinity from the library of oligonucleotides or analogs thereof,

wherein the combimer of step (d) is a member of the oligonucleotide library of (a) which comprises the known primary and secondary structure of step (a) and wherein N enumerated base positions comprises 2-40 nucleotides, and wherein the oligonucleotide library of (a) is reusable with multiple targets.

2. The method of claim 1 , further comprising:

selecting oligonucleotides or analogs thereof having an optimal binding domain from the library based upon the known primary structure of the combimer loop region of the identified combimer with desired binding affinity.

3. The method of claim 1 , wherein the oligonucleotides are chemically synthesized.

4. The method of claim 1 , wherein the oligonucleotides are enzymatically synthesized.

5. The method of claim 1 , wherein the oligonucleotides comprise DNA.

6. The method of claim 1 , wherein the oligonucleotides comprise RNA.

7. The method of claim 1 , wherein the oligonucleotides comprise both DNA and RNA in the same structure.

8. The method of claim 1 , further comprising catenating one or more combimers to produce a species with the desired binding affinity.

9. The method of claim 1 , wherein the combimer is chemically modified.

10. The method of claim 1 , wherein the enumerated region comprises 2-20 nucleotides.

11. The method of claim 10 , wherein the enumerated region comprises 2-10 nucleotides.

12. The method of claim 11 , wherein the enumerated region comprises 2-5 nucleotides.

13. The method of claim 1 , wherein the target is a protein.

14. The method of claim 1 , wherein the target is an organism.

15. The method of claim 14 , wherein the organism is a virus.

16. The method of claim 14 , wherein the organism is selected from the group consisting of cryptosporidium and giardia.

17. The method of claim 1 , wherein the target is a small molecule selected from the group consisting of toxins, environmental pollutants, drugs, and environmental contaminants.

18. The method of claim 1 , wherein binding affinity of the enumerated regions of the combimers is determined for more than one target.

19. The method of claim 1 , wherein the desired binding affinity is medium binding affinity of 10 −6 M<Kd<10 −2 M.

20. The method of claim 1 , wherein the desired binding affinity is high binding affinity of 10 −9 M<Kd<10 −6 M.

21. The method of claim 1 , wherein the loop is a stem loop or internal loop.

22. The method of claim 1 wherein the variable region is fully enumerated.

23. The method of claim 1 , further comprising repeating steps (b) through (d) with a larger enumerated region, N.

24. The method of claim 23 , wherein N is increased by 1-4 nucleotides.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2006
From: HUDSON, BRUCE S.; BORER, PHILIP N.
To: SYRACUSE UNIVERSITY
Reel/Frame 018101/0753 →
Continuity (2)
Provisional Application 60664457 · Mar 24, 2005
Related Publication 20060257900A1 · Nov 16, 2006